CTLA4 and hepatocellular carcinoma: To gain deeper insights into the changes in EFRG expression levels across distinct cell populations within HCC patients after PD-L1 and CTLA-4 immunotherapy, we selected the LIHC_GSE125449 aPDLaCTLA4 cohort for single-cell analysis (Figure 11A).